IXEMPRA Side Effects

5682442-X | Ataxia, Confusional State, Febrile Neutropenia, Haemoglobin Decreased, Hypoxia, Pleural Effusion, Pneumonitis
on Mar 21, 2008 Female patient from UNITED STATES , 80 years of age, weighting 160.9 lb, was diagnosed with endometrial cancer and was treated with Ixempra (View Usage). Patient experienced the following unwanted or unexpected effects: ataxia (What is ataxia?), confusional state, febrile neutropenia, haemoglobin decreased, hypoxia, pleural effusion, pneumonitis. Ixempra dosage: Dose: 40mg/m2 Iv Over 3hours On Day1 Initial Dose: 04-oct-2007 Last Dose: 27-dec-2007. During the same period patient was treated with DETROL (View Detrol Review and Detrol Label ), MAXIDEX (View Maxidex Review and Maxidex Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), SINEMET (View Sinemet Review and Sinemet Label ). Patient was hospitalized.

5671295-1 | Abdominal Pain, Cholelithiasis, Fatigue, Hepatic Enzyme Increased, Neutrophil Count Decreased, Odynophagia, Platelet Count Decreased, Recall Phenomenon
Patient was taking Ixempra (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), cholelithiasis, fatigue, hepatic enzyme increased, neutrophil count decreased, odynophagia, platelet count decreased, recall phenomenon on Mar 12, 2008 from UNITED STATES Additional patient health information: Female patient , 60 years of age, was diagnosed with breast cancer metastatic, nausea (What is nausea?) and. Ixempra dosage: . During the same period patient was treated with OXYCODONE HCL ER (View Oxycodone Hcl Er Review and Oxycodone Hcl Er Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), LORAZEPAM (Q8 Hrs Prn.restarted On 29feb08. Resumed On 29-feb-2008) (View Lorazepam Review and Lorazepam Label ), COMPAZINE (Then 25mg Suppositories. Was Held While In Hospital.) (View Compazine Review and Compazine Label ), ZOFRAN (To Oral Q8 Hrs. Then To Home 29-feb-2008) (View Zofran Review and Zofran Label ), LORTAB (1 Dosage Form = 5/500 (units Not Specified).) (View Lortab Review and Lortab Label ). Patient was hospitalized.

5671288-4 | Pancreatitis
Adverse event was reported on Mar 12, 2008 by a Female patient taking Ixempra (View Usage) (Dosage: 1 Dosage Form= 65(units Not Specified),1 Dose,single Injection.) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 47 years of age, After Ixempra was administered, patient had the following side effects: pancreatitis. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), EFFEXOR (View Effexor Review and Effexor Label ), LORTAB (1 Dosage Form = 7.5(units Not Specified), Q.4-6h. P.r.n.) (View Lortab Review and Lortab Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), ZOFRAN (Q 8-12 Hours Prn.) (View Zofran Review and Zofran Label ), MARINOL (1 Dosage Form = 5(units Not Specified).) (View Marinol Review and Marinol Label ). Patient was hospitalized.

5664706-9 | Acute Respiratory Distress Syndrome, Anaemia, Cardio-respiratory Arrest, Febrile Neutropenia, Hypocalcaemia, Hypokalaemia, Infection, Platelet Count Decreased, Prostate Infection
on Mar 07, 2008 Male patient from UNITED STATES , 59 years of age, weighting 187.4 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Ixempra (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, anaemia, cardio-respiratory arrest, febrile neutropenia, hypocalcaemia, hypokalaemia, infection (What is infection?), platelet count decreased, prostate infection. Ixempra dosage: Frequency: 3 Hrs On Day 1.. During the same period patient was treated with MITOXANTRONE HCL (Frequency: 30minutes On Day 1.) (View Mitoxantrone Hcl Review and Mitoxantrone Hcl Label ), PREDNISONE (Administered On Days 1 To 21.) (View Prednisone Review and Prednisone Label ), NEULASTA (Administered On Day 2.) (View Neulasta Review and Neulasta Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), ZOCOR (View Zocor Review and Zocor Label ), PIROXICAM (View Piroxicam Review and Piroxicam Label ), CELEBREX (View Celebrex Review and Celebrex Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ). Patient was hospitalized.


5660852-4 | Asthenia, Dizziness, Dyspnoea, Malignant Neoplasm Progression, Neuropathy Peripheral, Orthostatic Hypotension
on Mar 06, 2008 Male patient from UNITED STATES , 63 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Ixempra (View Usage). Patient had the following side effects: asthenia, dizziness (What is dizziness?), dyspnoea, malignant neoplasm progression, neuropathy peripheral, orthostatic hypotension. Ixempra dosage: 50-63 Mg. During the same period patient was treated with CETUXIMAB (View Cetuximab Review and Cetuximab Label ). Patient was hospitalized.

5651097-2 | Cerebrovascular Accident, Nervous System Disorder
Patient was taking Ixempra (View Usage). After Ixempra was administered, patient had the following side effects: cerebrovascular accident, nervous system disorder on Feb 22, 2008 from UNITED STATES Additional patient health information: Female patient , 58 years of age, . Ixempra dosage: . During the same period patient was treated with NARCOTIC ANALGESICS (View Narcotic Analgesics Review and Narcotic Analgesics Label ), ANTIDEPRESSANT (View Antidepressant Review and Antidepressant Label ).

5643350-3 | Ascites, Dehydration, Diarrhoea, Febrile Neutropenia, Ileus, Pancytopenia, Sepsis, Stomatitis
Adverse event was reported on Feb 22, 2008 by a Female patient taking Ixempra (View Usage) (Dosage: ) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 63 years of age, Patient experienced the following unwanted or unexpected effects: ascites, dehydration, diarrhoea, febrile neutropenia, ileus, pancytopenia, sepsis (What is sepsis?), stomatitis. During the same period patient was treated with ZANTAC 150 (View Zantac 150 Review and Zantac 150 Label ), BENADRYL (View Benadryl Review and Benadryl Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

5634946-3 | Ataxia, Confusional State, Febrile Neutropenia, Hypoxia, Pleural Effusion, Pneumonitis
on Feb 19, 2008 Female patient from UNITED STATES , 80 years of age, was diagnosed with endometrial cancer and was treated with Ixempra (View Usage). Patient had the following side effects: ataxia (What is ataxia?), confusional state, febrile neutropenia, hypoxia, pleural effusion, pneumonitis. Ixempra dosage: Dose: 40mg/m2 Iv Over 3hours On Day1 Initial Dose: 04-oct-2007 Last Dose: 27-dec-2007. Patient was hospitalized.

5630791-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Dehydration, Dysuria, Localised Oedema, Pancytopenia, Rash Pruritic, Stomatitis
on Feb 14, 2008 Female patient from UNITED STATES , 52 years of age, was diagnosed with breast cancer metastatic and was treated with Ixempra (View Usage). After Ixempra was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, dehydration, dysuria, localised oedema, pancytopenia, rash pruritic, stomatitis. Ixempra dosage: . During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), TAGAMET (View Tagamet Review and Tagamet Label ). Patient was hospitalized.

5627985-X | Lymphangiosis Carcinomatosa, Malignant Neoplasm Progression, Respiratory Failure
Patient was taking Ixempra (View Usage). Patient experienced the following unwanted or unexpected effects: lymphangiosis carcinomatosa, malignant neoplasm progression, respiratory failure on Feb 12, 2008 from UNITED STATES Additional patient health information: Female patient , 43 years of age, was diagnosed with breast cancer metastatic and. Ixempra dosage: . During the same period patient was treated with HERCEPTIN (View Herceptin Review and Herceptin Label ).

5626070-0 | Mucosal Inflammation, Pancytopenia
Adverse event was reported on Feb 11, 2008 by a Female patient taking Ixempra (View Usage) (Dosage: ) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 31 years of age, Patient had the following side effects: mucosal inflammation, pancytopenia.

5621905-X | Anorexia, Asthenia, Diarrhoea, Fatigue, Mouth Ulceration, Neuropathy Peripheral, Skin Exfoliation, Skin Ulcer, Vomiting
on Jan 10, 2008 Female patient from UNITED STATES , 50 years of age, weighting 249.1 lb, was diagnosed with breast cancer metastatic and was treated with Ixempra (View Usage). After Ixempra was administered, patient had the following side effects: anorexia, asthenia, diarrhoea, fatigue, mouth ulceration, neuropathy peripheral, skin exfoliation, skin ulcer, vomiting. Ixempra dosage: . During the same period patient was treated with PERCOCET (View Percocet Review and Percocet Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), ATIVAN (View Ativan Review and Ativan Label ), IMURAN (View Imuran Review and Imuran Label ), BENADRYL (View Benadryl Review and Benadryl Label ).

5621903-6 | Neutropenia, Skin Exfoliation, Skin Reaction
on Jan 08, 2008 Female patient from UNITED STATES , 74 years of age, was diagnosed with breast cancer metastatic and was treated with Ixempra (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia, skin exfoliation, skin reaction. Ixempra dosage: . During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), TAGAMET (View Tagamet Review and Tagamet Label ), DECADRON (View Decadron Review and Decadron Label ).

5621897-3 | Neutropenia, Thrombocytopenia
Patient was taking Ixempra (View Usage). Patient had the following side effects: neutropenia, thrombocytopenia on Dec 27, 2007 from UNITED STATES Additional patient health information: Female patient , 72 years of age, was diagnosed with breast cancer metastatic and. Ixempra dosage: . Patient was hospitalized.

5621896-1 | Asthenia, Fatigue, Heart Rate Increased, Metrorrhagia, Stomatitis
Adverse event was reported on Jan 03, 2008 by a Female patient taking Ixempra (View Usage) (Dosage: ) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 42 years of age, After Ixempra was administered, patient had the following side effects: asthenia, fatigue, heart rate increased, metrorrhagia, stomatitis.

5621894-8 | Infusion Site Pain, Infusion Site Swelling
on Dec 19, 2007 Female patient from UNITED STATES , 44 years of age, weighting 149.9 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ixempra (View Usage). Patient experienced the following unwanted or unexpected effects: infusion site pain, infusion site swelling. Ixempra dosage: 1st Dose On 23nov2007. 2nd Dose 07-dec-2007.. During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), AMBIEN (View Ambien Review and Ambien Label ).

5621892-4 | Angioedema
on Dec 17, 2007 Female patient from UNITED STATES , 56 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ixempra (View Usage). Patient had the following side effects: angioedema. Ixempra dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), XELODA (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

5621890-0 | Malignant Neoplasm Progression
Patient was taking Ixempra (View Usage). After Ixempra was administered, patient had the following side effects: malignant neoplasm progression on Jan 14, 2008 from UNITED STATES Additional patient health information: Female patient , 57 years of age, was diagnosed with breast cancer metastatic and. Ixempra dosage: Over Three Hours. During the same period patient was treated with XELODA (Bid) (View Xeloda Review and Xeloda Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), RESTORIL (View Restoril Review and Restoril Label ), SENOKOT (View Senokot Review and Senokot Label ).

5621887-0 | Diarrhoea, Nausea
Adverse event was reported on Dec 10, 2007 by a Female patient taking Ixempra (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 51 years of age, Patient experienced the following unwanted or unexpected effects: diarrhoea, nausea (What is nausea?). During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

5621886-9 | Flushing
on Dec 07, 2007 Female patient from UNITED STATES , 61 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ixempra (View Usage). Patient had the following side effects: flushing. Ixempra dosage: Initial Infusion-unk;second Infusion-07dec07.

5621877-8 | Burning Sensation, Rash
on Dec 05, 2007 Female patient from UNITED STATES , 58 years of age, weighting 154.3 lb, was treated with Ixempra (View Usage). After Ixempra was administered, patient had the following side effects: burning sensation, rash (What is rash?). Ixempra dosage: .

5621866-3 | Alopecia
Patient was taking Ixempra (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia on Nov 26, 2007 from UNITED STATES Additional patient health information: Female patient , 45 years of age, weighting 134.5 lb, was diagnosed with breast cancer stage iv and. Ixempra dosage: .

5621860-2 | Headache, Malignant Neoplasm Progression, Nausea
Adverse event was reported on Nov 19, 2007 by a Female patient taking Ixempra (View Usage) (Dosage: Ixempra Received On 15-nov-2007 And On 19-nov-2007.) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 42 years of age, Patient had the following side effects: headache (What is headache?), malignant neoplasm progression, nausea (What is nausea?). During the same period patient was treated with PROTONIX (View Protonix Review and Protonix Label ), TESSALON (View Tessalon Review and Tessalon Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ), TUSSIONEX (View Tussionex Review and Tussionex Label ).

5621858-4 | Arthralgia, Bone Pain
on Dec 31, 2007 Female patient from UNITED STATES , 50 years of age, was diagnosed with breast cancer metastatic and was treated with Ixempra (View Usage). After Ixempra was administered, patient had the following side effects: arthralgia, bone pain. Ixempra dosage: . During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), DECADRON (View Decadron Review and Decadron Label ), PEPCID (View Pepcid Review and Pepcid Label ).

5621857-2 | Pancytopenia
on Nov 19, 2007 Female patient from UNITED STATES , 30 years of age, was treated with Ixempra (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia. Ixempra dosage: . During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

5621855-9 | Paraesthesia
Patient was taking Ixempra (View Usage). Patient had the following side effects: paraesthesia on Nov 12, 2007 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 154.3 lb, was diagnosed with breast cancer (What is breast cancer?) and. Ixempra dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SINGULAIR (View Singulair Review and Singulair Label ), PAROXETINE (View Paroxetine Review and Paroxetine Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ).

5621854-7 | Neutropenia
Adverse event was reported on Dec 05, 2007 by a Female patient taking Ixempra (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 61 years of age, After Ixempra was administered, patient had the following side effects: neutropenia. Patient was hospitalized.

5621851-1 | Dysphagia, Dysphasia
on Dec 13, 2007 Female patient from UNITED STATES , 51 years of age, was diagnosed with breast cancer metastatic and was treated with Ixempra (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, dysphasia. Ixempra dosage: 1 Infusion Is Given..

5611332-3 |
on Jan 30, 2008 Female patient from UNITED STATES , 47 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ixempra (View Usage). . Ixempra dosage: .

5608407-1 | Gait Disturbance, Incontinence, Lethargy, Rash
Patient was taking Ixempra (View Usage). After Ixempra was administered, patient had the following side effects: gait disturbance, incontinence, lethargy, rash (What is rash?) on Jan 25, 2008 from UNITED STATES Additional patient health information: Female patient , 70 years of age, was diagnosed with breast cancer metastatic and. Ixempra dosage: . During the same period patient was treated with ALOXI (View Aloxi Review and Aloxi Label ), BENADRYL (View Benadryl Review and Benadryl Label ), TAGAMET (View Tagamet Review and Tagamet Label ).

5607903-0 | Acute Respiratory Failure, Blood Thyroid Stimulating Hormone Increased, Cardiac Failure Congestive, Cardiomyopathy, Colitis Ischaemic, Hypersensitivity, Hypotension, Liver Function Test Abnormal, Metabolic Acidosis
Adverse event was reported on Jan 25, 2008 by a Female patient taking Ixempra (View Usage) (Dosage: ) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 82 years of age, weighting 134.5 lb, Patient experienced the following unwanted or unexpected effects: acute respiratory failure, blood thyroid stimulating hormone increased, cardiac failure congestive, cardiomyopathy (What is cardiomyopathy?), colitis ischaemic, hypersensitivity, hypotension, liver function test abnormal, metabolic acidosis. During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), PEPCID (View Pepcid Review and Pepcid Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), STEROIDS (View Steroids Review and Steroids Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), COREG (View Coreg Review and Coreg Label ), LASIX (View Lasix Review and Lasix Label ), BENAZEPRIL HCL (View Benazepril Hcl Review and Benazepril Hcl Label ). Patient was hospitalized.

5607902-9 | Confusional State, Depressed Level Of Consciousness, Respiratory Depression
on Jan 24, 2008 Female patient from UNITED STATES , 45 years of age, was diagnosed with breast cancer metastatic and was treated with Ixempra (View Usage). Patient had the following side effects: confusional state, depressed level of consciousness, respiratory depression. Ixempra dosage: .

5605949-X | Acute Respiratory Distress Syndrome, Anaemia, Cardio-respiratory Arrest, Febrile Neutropenia, Hypocalcaemia, Hypokalaemia, Prostate Infection, Renal Failure
on Jan 24, 2008 Male patient from UNITED STATES , 59 years of age, weighting 187.4 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Ixempra (View Usage). After Ixempra was administered, patient had the following side effects: acute respiratory distress syndrome, anaemia, cardio-respiratory arrest, febrile neutropenia, hypocalcaemia, hypokalaemia, prostate infection, renal failure. Ixempra dosage: Frequency: 3 Hrs On Day 1.. During the same period patient was treated with MITOXANTRONE HCL (Frequency: 30minutes On Day 1.) (View Mitoxantrone Hcl Review and Mitoxantrone Hcl Label ), PREDNISONE TAB (Administered On Days 1 To 21.) (View Prednisone Tab Review and Prednisone Tab Label ), PEGFILGRASTIM (Administered On Day 2.) (View Pegfilgrastim Review and Pegfilgrastim Label ). Patient was hospitalized.

5604768-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Dysuria, Localised Oedema, Pancytopenia, Rash Pruritic, Stomatitis
Patient was taking Ixempra (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, dysuria, localised oedema, pancytopenia, rash pruritic, stomatitis on Jan 24, 2008 from UNITED STATES Additional patient health information: Female patient , 52 years of age, was diagnosed with breast cancer metastatic and. Ixempra dosage: . Patient was hospitalized.

5602760-0 | Dyspnoea, Pancytopenia, Pulmonary Toxicity, Respiratory Arrest
Adverse event was reported on Jan 17, 2008 by a Female patient taking Ixempra (View Usage) (Dosage: ) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 60 years of age, Patient had the following side effects: dyspnoea, pancytopenia, pulmonary toxicity, respiratory arrest. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), ALOXI (View Aloxi Review and Aloxi Label ), DECADRON (View Decadron Review and Decadron Label ), ZANTAC (View Zantac Review and Zantac Label ), BENADRYL (View Benadryl Review and Benadryl Label ). Patient was hospitalized.

5599883-1 | Blood Glucose Increased
on Jan 18, 2008 Female patient from UNITED STATES , 72 years of age, was diagnosed with breast cancer metastatic and was treated with Ixempra (View Usage). After Ixempra was administered, patient had the following side effects: blood glucose increased. Ixempra dosage: .

5593641-X | Malignant Neoplasm Progression
on Jan 14, 2008 Female patient from UNITED STATES , 57 years of age, was diagnosed with breast cancer metastatic and was treated with Ixempra (View Usage). Patient experienced the following unwanted or unexpected effects: malignant neoplasm progression. Ixempra dosage: Over Three Hours. During the same period patient was treated with XELODA (Bid) (View Xeloda Review and Xeloda Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), RESTORIL (View Restoril Review and Restoril Label ), SENOKOT (View Senokot Review and Senokot Label ).

5585778-6 | Acute Respiratory Failure, Blood Thyroid Stimulating Hormone Increased, Cardiac Failure Congestive, Hypersensitivity
Patient was taking Ixempra (View Usage). Patient had the following side effects: acute respiratory failure, blood thyroid stimulating hormone increased, cardiac failure congestive, hypersensitivity on Jan 08, 2008 from UNITED STATES Additional patient health information: Female patient , 82 years of age, weighting 134.5 lb, was diagnosed with breast cancer metastatic and. Ixempra dosage: . During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), PEPCID (View Pepcid Review and Pepcid Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), STEROIDS (View Steroids Review and Steroids Label ). Patient was hospitalized.

5583094-X | Gait Disturbance, Incontinence, Lethargy, Rash
Adverse event was reported on Jan 03, 2008 by a Female patient taking Ixempra (View Usage) (Dosage: ) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 70 years of age, After Ixempra was administered, patient had the following side effects: gait disturbance, incontinence, lethargy, rash (What is rash?). During the same period patient was treated with ALOXI (View Aloxi Review and Aloxi Label ), BENADRYL (View Benadryl Review and Benadryl Label ), TAGAMET (View Tagamet Review and Tagamet Label ).

5581410-6 | Pancreatitis
on Dec 31, 2007 Female patient from UNITED STATES , 47 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ixempra (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis. Ixempra dosage: 1 Dosage Form= 65. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), EFFEXOR (View Effexor Review and Effexor Label ), LORTAB (Q.4-6h. P.r.n.) (View Lortab Review and Lortab Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), ZOFRAN (View Zofran Review and Zofran Label ), MARINOL (View Marinol Review and Marinol Label ). Patient was hospitalized.

5576756-1 | Colitis Ischaemic, Hepatorenal Failure, Loss Of Consciousness, Pyrexia, Sepsis
on Dec 19, 2007 Female patient from UNITED STATES , 48 years of age, was diagnosed with breast cancer stage iv and was treated with Ixempra (View Usage). Patient had the following side effects: colitis ischaemic, hepatorenal failure, loss of consciousness, pyrexia, sepsis (What is sepsis?). Ixempra dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), VICODIN (View Vicodin Review and Vicodin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

5574836-8 | Acute Respiratory Distress Syndrome, Anaemia, Cardio-respiratory Arrest, Febrile Neutropenia, Hypocalcaemia, Hypokalaemia, Prostate Infection, Renal Failure
Patient was taking Ixempra (View Usage). After Ixempra was administered, patient had the following side effects: acute respiratory distress syndrome, anaemia, cardio-respiratory arrest, febrile neutropenia, hypocalcaemia, hypokalaemia, prostate infection, renal failure on Dec 21, 2007 from UNITED STATES Additional patient health information: Male patient , 59 years of age, weighting 187.4 lb, was diagnosed with prostate cancer (What is prostate cancer?) and. Ixempra dosage: . During the same period patient was treated with MITOXANTRONE HCL (View Mitoxantrone Hcl Review and Mitoxantrone Hcl Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

5571854-0 | Malignant Neoplasm Progression
Adverse event was reported on Dec 18, 2007 by a Female patient taking Ixempra (View Usage) (Dosage: ) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 57 years of age, Patient experienced the following unwanted or unexpected effects: malignant neoplasm progression. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), RESTORIL (View Restoril Review and Restoril Label ), SENOKOT (View Senokot Review and Senokot Label ).

5570719-8 | Acute Respiratory Failure, Blood Thyroid Stimulating Hormone Increased, Cardiac Failure Congestive, Hypersensitivity
on Dec 17, 2007 Female patient from UNITED STATES , 82 years of age, weighting 134.5 lb, was diagnosed with breast cancer metastatic and was treated with Ixempra (View Usage). Patient had the following side effects: acute respiratory failure, blood thyroid stimulating hormone increased, cardiac failure congestive, hypersensitivity. Ixempra dosage: . During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), PEPCID (View Pepcid Review and Pepcid Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), STEROIDS (View Steroids Review and Steroids Label ). Patient was hospitalized.

5568224-8 | Lymphangiosis Carcinomatosa, Malignant Neoplasm Progression, Respiratory Failure
on Dec 13, 2007 Female patient from UNITED STATES , 43 years of age, was diagnosed with breast cancer metastatic and was treated with Ixempra (View Usage). After Ixempra was administered, patient had the following side effects: lymphangiosis carcinomatosa, malignant neoplasm progression, respiratory failure. Ixempra dosage: . During the same period patient was treated with HERCEPTIN (View Herceptin Review and Herceptin Label ).

5565215-8 | Acute Respiratory Failure, Blood Thyroid Stimulating Hormone Increased, Hypersensitivity
Patient was taking Ixempra (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure, blood thyroid stimulating hormone increased, hypersensitivity on Dec 12, 2007 from UNITED STATES Additional patient health information: Female patient , 82 years of age, weighting 134.5 lb, was diagnosed with breast cancer metastatic and. Ixempra dosage: . During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), PEPCID (View Pepcid Review and Pepcid Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), STEROIDS (View Steroids Review and Steroids Label ). Patient was hospitalized.

5513133-3 | Ataxia, Dehydration, Haemoglobin Decreased, Hyponatraemia
Adverse event was reported on Nov 06, 2007 by a Male patient taking Ixempra (View Usage) (Dosage: 20mg/m2 On Day 1,8,15. Cyc 28days) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , 63 years of age, weighting 156.5 lb, Patient had the following side effects: ataxia (What is ataxia?), dehydration, haemoglobin decreased, hyponatraemia. Patient was hospitalized.